155 related articles for article (PubMed ID: 29663513)
1. A variant of GRK5 is associated with the therapeutic efficacy of repaglinide in Chinese Han patients with type 2 diabetes mellitus.
Shang Z; Han F; Zhou X; Bao Z; Zhu J; Wang T; Lu Q; Du L; Li W; Lv D; Yin X
Drug Dev Res; 2018 May; 79(3):129-135. PubMed ID: 29663513
[TBL] [Abstract][Full Text] [Related]
2. PPARD rs2016520 polymorphism affects repaglinide response in Chinese Han patients with type 2 diabetes mellitus.
Song JF; Wang T; Zhu J; Zhou XY; Lu Q; Guo H; Zhang F; Wang Y; Li W; Wang DD; Cui YW; Lv DM; Yin XX
Clin Exp Pharmacol Physiol; 2015 Jan; 42(1):27-32. PubMed ID: 25311380
[TBL] [Abstract][Full Text] [Related]
3. A Variation in the ABCC8 Gene Is Associated with Type 2 Diabetes Mellitus and Repaglinide Efficacy in Chinese Type 2 Diabetes Mellitus Patients.
Zhou X; Chen C; Yin D; Zhao F; Bao Z; Zhao Y; Wang X; Li W; Wang T; Jin Y; Lv D; Lu Q; Yin X
Intern Med; 2019 Aug; 58(16):2341-2347. PubMed ID: 31118371
[TBL] [Abstract][Full Text] [Related]
4. Association of GRK5 variant rs10886471 with the therapeutic effect of repaglinide in patients of type 2 diabetes mellitus in Peshawar, Pakistan.
Ijaz K; Zakiullah -; Shah H; Ali S; Raziq M; Bahadar H
Pak J Pharm Sci; 2024 Mar; 37(2(Special)):417-421. PubMed ID: 38822544
[TBL] [Abstract][Full Text] [Related]
5. NAMPT -3186C/T polymorphism affects repaglinide response in Chinese patients with Type 2 diabetes mellitus.
Sheng FF; Dai XP; Qu J; Lei GH; Lu HB; Wu J; Xu XJ; Pei Q; Dong M; Liu YZ; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):550-4. PubMed ID: 21631570
[TBL] [Abstract][Full Text] [Related]
6. Effects of NOS1AP rs12742393 polymorphism on repaglinide response in Chinese patients with type 2 diabetes mellitus.
Wang T; Wang Y; Lv DM; Song JF; Lu Q; Gao X; Zhang F; Guo H; Li W; Yin XX
Pharmacotherapy; 2014 Feb; 34(2):131-9. PubMed ID: 24338736
[TBL] [Abstract][Full Text] [Related]
7. IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population.
Huang Q; Yin JY; Dai XP; Pei Q; Dong M; Zhou ZG; Huang X; Yu M; Zhou HH; Liu ZQ
Acta Pharmacol Sin; 2010 Jun; 31(6):709-17. PubMed ID: 20523342
[TBL] [Abstract][Full Text] [Related]
8. Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients.
Huang Q; Yin JY; Dai XP; Wu J; Chen X; Deng CS; Yu M; Gong ZC; Zhou HH; Liu ZQ
Eur J Clin Pharmacol; 2010 Dec; 66(12):1207-15. PubMed ID: 20809084
[TBL] [Abstract][Full Text] [Related]
9. NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes.
Gong ZC; Huang Q; Dai XP; Lei GH; Lu HB; Yin JY; Xu XJ; Qu J; Pei Q; Dong M; Zhou BT; Shen J; Zhou G; Zhou HH; Liu ZQ
Br J Clin Pharmacol; 2012 Sep; 74(3):501-9. PubMed ID: 22296034
[TBL] [Abstract][Full Text] [Related]
10. GRK5 intronic (CA)n polymorphisms associated with type 2 diabetes in Chinese Hainan Island.
Xia Z; Yang T; Wang Z; Dong J; Liang C
PLoS One; 2014; 9(3):e90597. PubMed ID: 24594703
[TBL] [Abstract][Full Text] [Related]
11. KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) polymorphisms affect therapeutic efficacy of repaglinide in Chinese patients with type 2 diabetes.
Yu M; Xu XJ; Yin JY; Wu J; Chen X; Gong ZC; Ren HY; Huang Q; Sheng FF; Zhou HH; Liu ZQ
Clin Pharmacol Ther; 2010 Mar; 87(3):330-5. PubMed ID: 20054294
[TBL] [Abstract][Full Text] [Related]
12. KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese type 2 diabetic patients.
Dai XP; Huang Q; Yin JY; Guo Y; Gong ZC; Lei MX; Jiang TJ; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2012 May; 39(5):462-8. PubMed ID: 22414228
[TBL] [Abstract][Full Text] [Related]
13. Effect of genetic polymorphism of UCP2-866 G/A on repaglinide response in Chinese patients with type 2 diabetes.
Wang S; Se YM; Liu ZQ; Lei MX; Hao-BoYang ; Sun ZX; Nie SD; Zeng XM; Wu J
Pharmazie; 2012 Jan; 67(1):74-9. PubMed ID: 22393835
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics.
Niemi M; Backman JT; Kajosaari LI; Leathart JB; Neuvonen M; Daly AK; Eichelbaum M; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2005 Jun; 77(6):468-78. PubMed ID: 15961978
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine markedly raises the plasma concentrations of repaglinide.
Kajosaari LI; Niemi M; Neuvonen M; Laitila J; Neuvonen PJ; Backman JT
Clin Pharmacol Ther; 2005 Oct; 78(4):388-99. PubMed ID: 16198658
[TBL] [Abstract][Full Text] [Related]
16. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
[TBL] [Abstract][Full Text] [Related]
17. Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients.
He YY; Zhang R; Shao XY; Hu C; Wang CR; Lu JX; Bao YQ; Jia WP; Xiang KS
Acta Pharmacol Sin; 2008 Aug; 29(8):983-9. PubMed ID: 18664331
[TBL] [Abstract][Full Text] [Related]
18. Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese population.
Pei Q; Liu JY; Yin JY; Yang GP; Liu SK; Zheng Y; Xie P; Guo CX; Luo M; Zhou HH; Li X; Liu ZQ
Eur J Clin Pharmacol; 2018 Aug; 74(8):1021-1028. PubMed ID: 29748863
[TBL] [Abstract][Full Text] [Related]
19. Impact of retinol binding protein 4 polymorphism on rosiglitazone response in Chinese type 2 diabetic patients.
Zhou F; Huang Q; Dai X; Yin J; Wu J; Zhou H; Gong Z; Liu Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 36(10):949-57. PubMed ID: 22086013
[TBL] [Abstract][Full Text] [Related]
20. A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese.
Qin W; Zhang R; Hu C; Wang CR; Lu JY; Yu WH; Bao YQ; Xiang KS; ; Jia WP
Acta Pharmacol Sin; 2010 Apr; 31(4):450-4. PubMed ID: 20305679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
